These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16603794)

  • 41. Targeting neurite growth inhibitors to induce CNS regeneration.
    Kastin AJ; Pan W
    Curr Pharm Des; 2005; 11(10):1247-53. PubMed ID: 15853681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth.
    Ghiani CA; Ying Z; de Vellis J; Gomez-Pinilla F
    Glia; 2007 Jul; 55(9):966-75. PubMed ID: 17497667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of neurotrophic factors in nerve regeneration.
    Gordon T
    Neurosurg Focus; 2009 Feb; 26(2):E3. PubMed ID: 19228105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RGMa inhibition promotes axonal growth and recovery after spinal cord injury.
    Hata K; Fujitani M; Yasuda Y; Doya H; Saito T; Yamagishi S; Mueller BK; Yamashita T
    J Cell Biol; 2006 Apr; 173(1):47-58. PubMed ID: 16585268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain.
    Li HP; Komuta Y; Kimura-Kuroda J; van Kuppevelt TH; Kawano H
    J Neurotrauma; 2013 Mar; 30(5):413-25. PubMed ID: 23438307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of Eph receptors and ephrins in the normal and damaged adult CNS.
    Goldshmit Y; McLenachan S; Turnley A
    Brain Res Rev; 2006 Sep; 52(2):327-45. PubMed ID: 16774788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS.
    Kurihara Y; Saito Y; Takei K
    Neuroscience; 2017 Jul; 356():265-274. PubMed ID: 28571719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.
    Douglas MR; Morrison KC; Jacques SJ; Leadbeater WE; Gonzalez AM; Berry M; Logan A; Ahmed Z
    Brain; 2009 Nov; 132(Pt 11):3102-21. PubMed ID: 19783665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A.
    Pasterkamp RJ; Anderson PN; Verhaagen J
    Eur J Neurosci; 2001 Feb; 13(3):457-71. PubMed ID: 11168552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Olfactory Ensheathing Cell Transplantation after a Complete Spinal Cord Transection Mediates Neuroprotective and Immunomodulatory Mechanisms to Facilitate Regeneration.
    Khankan RR; Griffis KG; Haggerty-Skeans JR; Zhong H; Roy RR; Edgerton VR; Phelps PE
    J Neurosci; 2016 Jun; 36(23):6269-86. PubMed ID: 27277804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of root replantation and neurotrophic factor treatment on long-term motoneuron survival and axonal regeneration after C7 spinal root avulsion.
    Lang EM; Schlegel N; Sendtner M; Asan E
    Exp Neurol; 2005 Aug; 194(2):341-54. PubMed ID: 16022862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oligodendrocyte precursor cells: reactive cells that inhibit axon growth and regeneration.
    Chen ZJ; Negra M; Levine A; Ughrin Y; Levine JM
    J Neurocytol; 2002; 31(6-7):481-95. PubMed ID: 14501218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling.
    Mingorance A; Solé M; Munetón V; Martínez A; Nieto-Sampedro M; Soriano E; del Río JA
    FASEB J; 2006 Mar; 20(3):491-3. PubMed ID: 16407455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental strategies to promote functional recovery after peripheral nerve injuries.
    Gordon T; Sulaiman O; Boyd JG
    J Peripher Nerv Syst; 2003 Dec; 8(4):236-50. PubMed ID: 14641648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury.
    Keefe KM; Sheikh IS; Smith GM
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regeneration beyond the glial scar.
    Silver J; Miller JH
    Nat Rev Neurosci; 2004 Feb; 5(2):146-56. PubMed ID: 14735117
    [No Abstract]   [Full Text] [Related]  

  • 58. Neuronal growth-promoting and inhibitory cues in neuroprotection and neuroregeneration.
    Skaper SD
    Methods Mol Biol; 2012; 846():13-22. PubMed ID: 22367797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.
    Peng X; Zhou Z; Hu J; Fink DJ; Mata M
    J Biol Chem; 2010 Jan; 285(4):2783-95. PubMed ID: 19901030
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.